Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease

被引:9
作者
Qadan, Laila R. [1 ]
Ahmed, Adel A. [2 ]
Safar, Hussein A. [3 ]
Al-Bader, Marzouk A. [3 ]
Ali, Amr A. [4 ]
机构
[1] Kuwait Univ, Fac Med, Dept Med Endocrinol, Safat 13060, Kuwait
[2] Kuwait Univ, Fac Med, Dept Radiol, Safat 13060, Kuwait
[3] Minist Hlth, Mubarak Al Kabeer Hosp, Dept Surg, Kuwait, Kuwait
[4] Minist Hlth, Mubarak Al Kabeer Hosp, Dept Radiol, Kuwait, Kuwait
关键词
peripheral vascular disease; peripheral arterial disease; metabolic syndrome; critical leg ischemia;
D O I
10.1177/0003319707304582
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The aim of this cross-sectional study was to determine the prevalence of metabolic syndrome (MetS) and its components among 100 patients with progressive peripheral arterial disease (PAD) referred for diagnostic angiography in preparation for a revascularization procedure. The prevalence of MetS was more than 95%. Diabetes mellitus was the most prevalent component followed by hypertension and low high-density lipoprotein. Almost half the patients aggregated in the highest metabolic score category. A direct relationship was identified between the number of MetS components and serum uric acid (P = .001.) and C-reactive protein (P = .826), whereas an inverse relationship was seen between the clustering of components and androgen levels in men (P < .001). For PAD, which could have a benign clinical course, early screening for MetS might identify those at greater risk of failing conservative therapy and progressing to a more aggressive atherosclerotic disease typically associated with high morbidity and mortality.
引用
收藏
页码:198 / 202
页数:5
相关论文
共 36 条
[1]   Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure [J].
Anker, SD ;
Leyva, F ;
PooleWilson, PA ;
Kox, WJ ;
Stevenson, JC ;
Coats, AJS .
HEART, 1997, 78 (01) :39-43
[2]  
Barani J, 2005, INT ANGIOL, V24, P59
[3]   Contribution of age and declining androgen levels to features of the metabolic syndrome in men [J].
Blouin, K ;
Després, JP ;
Couillard, C ;
Tremblay, A ;
Prud'homme, D ;
Bouchard, C ;
Tchernof, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (08) :1034-1040
[4]   PLASMA-LIPIDS AS A RISK FACTOR IN PERIPHERAL VASCULAR-DISEASE [J].
CARDIA, G ;
GRISORIO, D ;
IMPEDOVO, G ;
LILLO, A ;
REGINA, G .
ANGIOLOGY, 1990, 41 (01) :19-22
[5]   Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[6]  
Dunajska K, 2004, Aging Male, V7, P197
[7]   RELATIONSHIP BETWEEN RESISTANCE TO INSULIN-MEDIATED GLUCOSE-UPTAKE, URINARY URIC-ACID CLEARANCE, AND PLASMA URIC-ACID CONCENTRATION [J].
FACCHINI, F ;
CHEN, YDI ;
HOLLENBECK, CB ;
REAVEN, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21) :3008-3011
[8]   The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study [J].
Ford, ES .
ATHEROSCLEROSIS, 2004, 173 (02) :309-314
[9]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[10]   Epidemiology and pathophysiology of lower extremity peripheral arterial disease [J].
Garcia, LA .
JOURNAL OF ENDOVASCULAR THERAPY, 2006, 13 :3-9